Venture Capital Tracker is a free research layer for startup funding, venture capital firms, investor discovery, and source-backed market coverage.
Venture Capital Tracker logo
Venture Capital Tracker
Venture capital intelligence

Track startup funding.
Find the investors behind it.

A practical, source-backed view of funding rounds, VC firms, and the companies they back — built for faster founder and investor research.

Try a16z seed investors New York Explore startups
Just in
Find an investor Shortlist firms by stage, location, and focus. Open investors Explore startup coverage See the companies and sectors in our research. Browse startups Follow the deal flow Keep up with the latest rounds and fund closes. View latest signals

Coverage snapshot

Know what’s in the dataset.

A growing research layer across funds, companies, and source-backed venture coverage.

849

VC firms

Profiles with stage, focus, and contact links.

2,146

Startups

Companies appearing in our funding coverage.

1

Latest signals

Fund closes and rounds in the investment feed.

1,483

Research articles

Analysis, explainers, and market roundups.

Deal flow

Latest funding & fund-close signals

A date-first view of the newest entries in the Venture Capital Tracker feed. Open each item for the full context and source trail.

View full feed
Funding round Nov 13

LangChain raises $300M Series C at stated $3B valuation led by CapitalG

LangChain announced a $300M Series C at a stated $3B valuation on November 13, 2026. CapitalG led with participation from GIC, DFJ Growth, IVP, Sapphire Ventures and others. Issuer release says $460M cumulative capital, not a fresh financing tranche. Pre/post-money valuation basis and separate legal close date were not disclosed. 7,000+ LangSmith organizations is issuer-reported product use, not audited paid contracts.

Research desk

Latest venture capital research

Read all research
Research Nov 13

LangChain Raises $300M at $3B: Inside LangSmith's AI-Agent Business

Free developer tools helped LangChain spread; LangSmith is the commercial bet on making unpredictable AI agents testable, governable and reliable. We examine what customers actually buy, the costs behind its pricing, and the evidence still missing.

Read article
Research Nov 13

Beyond Next-Token AI: NCM, Diffusion Models and the Startup Funding Race

Which startups can make AI generation faster without losing accuracy? An evidence-based look at NCM, Mercury 3, DiffuSpace Clover, Zyphra, funding rounds and commercial costs.

Read article
Research Nov 13

Norwest Raises $4B Fund 18: Founder Fit, Cheque Sizes and LP Questions

The new pool spans venture and growth equity, not AI alone. Norwest publicly describes different investment sizes and ownership routes, while its fund-level LP commitments, fees and first deployments remain undisclosed.

Read article
Research Nov 13

Biotech Funding 2026: Latest Startup Rounds, Investors and Venture Deals

A dated biotech funding tracker covering notable 2026 rounds, investor syndicates, AI drug discovery, European deals and the difference between equity, debt, licensing and fund closes.

Read article

Go deeper

Research the market your way.

Use the structured pages when you need a shortlist, a company read, or a plain-English answer about how venture capital works.

01

VC firms

Filter 849 investor profiles.

 02

Startups

Explore 2,146 companies in coverage.

03

Glossary

Get clear on the terms behind the deal.
Built from structured profiles and source-backed editorial coverage. How we curate the data